BNTC
BENITEC BIOPHARMA (BNTC) Posts $45.5M Annual Loss, Eyes Pivotal BB-301 Trial in 2027
The gene therapy developer closed fiscal 2026 with $180 million in cash, a fully enrolled high-dose cohort and FDA talks on a pivotal study design.
BNTC
The gene therapy developer closed fiscal 2026 with $180 million in cash, a fully enrolled high-dose cohort and FDA talks on a pivotal study design.
PLAY
The entertainment and dining operator posted a $12.5 million quarterly net loss on revenue of $544.1 million, down 2.4% from a year earlier.
IMMR
Haptics licensor posts Q1 fiscal 2027 revenue of $294.4 million and declares its sixteenth consecutive quarterly dividend of $0.075 per share.
ABAT
The Reno-based recycler posted a gross loss of $3.1 million but turned adjusted gross profit positive at $1.7 million and ended the year debt-free with $49.5 million in cash.
LAES
The post-quantum chipmaker reaffirmed FY2026 revenue guidance of $27M to $36M and ended June with $486.1 million in cash.
KR
Kroger reported adjusted EPS of $1.09 on 0.2% identical sales growth and lowered its full-year comparable sales forecast to 0.2%-0.8%.
MNY
The Hong Kong and Singapore comparison platform saw Q2 revenue fall to $15.8 million as cash incentives are deducted from revenue under IFRS.
Earnings
The Danish cell-counting specialist grew revenue 3% to DKK 511.1 million in 2025/26 and expects DKK 545-575 million in the new financial year.
IMPP
The Greek shipowner reported net income of $34.8 million on all-time high quarterly revenues, with no debt and $245.2 million in cash.
TSM
The Taiwanese foundry reported August sales of NT$514.81 billion, up 10.1% from July and 53.3% from a year earlier, with eight-month revenue 39.3% higher.
M
Bloomingdale's grew 11.3% and net income doubled to $169 million, helped by $98 million of tariff refunds; adjusted EPS guidance raised to $2.15-$2.35.
Earnings
The French aerospace engineering group reported first-half 2026 turnover of €78.1M, down 3.1%, while EBITDA rose 21.4% to €6.2M.